Shanhu Health Technology Co., Ltd
One-stop Solution for Clinical Data and Drug Supply Management

Over the last seven years, China’s pharmaceutical industry has been bolstered, and huge drug innovation has been seen as a top priority. While Chinese pharma and biotech companies are emerging in the global pharma market, Shanhu Health, since 2015, has played a vital part in helping these players to thrive.

Shanhu is a China-renowned clinical trial and research management company that provides cloud-based digital intelligence platforms and strives to grow into the most vigorous pharma technology enterprise in China. Its solutions are powered by industry-leading intelligent (brainlike) engines and cover the gamut of closed-loop drug supply management.

“Shanhu joins hands with various parties and grants new vitality to the clinical research space with digital intelligence and accelerates the development of health research in China,” says Danni Liu, CEO of Shanhu.

The company helps pharma brands implement complicated trials with basket, umbrella, and adaptive designs to accelerate the process of clinical trials.

Shanhu Health’s IRTON, commonly known as IRT, delivers both Randomization and Trial Supply Management in clinical studies. Most notably, prediction models in IRTON empower its customers to precisely manufacture and effectively dispense investigational products (IP). Based on the Monte Carlo model, study actuals (enrollment rate, site number, packaging size), and simulated scenarios, powerful scenario modelling enables biopharma companies to make data-driven manufacture plan. Besides, IRTON also supports one-way and two-way data transmission between a broad range of clinical trial systems, including CTMS, WMS, EDC (globalvendor), etc.

Meanwhile, Shanhu Health’s EDCON, commonly known as EDC (Electronic Data Capture), is an easy-to-use and low-code platform which simplifies and improves complex research database-building processes. Using low-code functionalities, the data management department can execute complex CRF (Case Report Form) library construction and logic verification through seamless drag-and-drop features. In addition, EDCON supports the online collaborative reviews of CRF designs, real-time revisions, and batch online testings with remarkable security, speed, and agility, as it reduces the UAT time from five business days to 30 minutes.
Robert Ingersoll once said, “We rise by lifting others,” illustrating the significance of supporting each other.

Since it takes inspiration from California’s Sequoia National Forest, this idea becomes the cornerstone of Shanhu Health.

The sequoia trees withstand harsh environmental conditions owing to an underground network of intertwined roots. This concealed but very real connectedness between the adjacent trees enables them to support each other, despite their unfavourable physical characteristics and related geographic and climatic factors.

Shanhu forges collaborative and supportive relationships with its clients, enabling them to accelerate their drug development operations and bring novel drugs to patients faster. The company aims to assimilate the essence of sequoia’s vitality and spirit of interaction and set new benchmarks of customer-centricity in the global pharma space. With such a win-win and collaborative spirit, Shanhu has enabled numerous biopharma and biotech giants to considerably reduce clinical trial costs and predict demand.

At Shanhu Health, we leverage our clinical trial expertise and pioneering technology to help our customers with complex study development challenges. We aim to help pharma companies overcome common hurdles in clinical trials and bring much-needed treatments to patients faster

In the emergence of the COVID-19 pandemic, when a shedload of biopharmas were speeding their development of vaccines and drugs to be saviour of humanity, Shanhu Health helped these companies to accelerate their studies by making clinical trial systems live within weeks. By the end of 2022, Shanhu’s solutions have been used in the clinical development of over 600 approved medical treatments, over 70 of which are MRCT (Multi-Regional Clinical Trial). The company has also supported over 70 global studies, more than 2000 institutions, and numerous audits across 1000 plus cities worldwide.

The company’s seasoned life sciences experts develop flexible and customised solutions that help users cope with complex decisionmaking, risk pre-control, and stable operations management. This pre-work helps pharma companies overcome common hurdles in clinical trials and take their system live before a trial begins. With a peerless baseline familiarity with the challenges and opportunities in the clinical drug supply arena, Shanhu Health Technology Co., Ltd. aims to collaborate with partners locally and across APAC to foster faster drug formulation and development.

“At Shanhu Health, we leverage our clinical trial expertise and pioneering technology to help our customers with complex study development challenges. We aim to help pharma companies overcome common hurdles in clinical trials and bring much-needed treatments to patients faster,” concludes Liu.